Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT

[1] Ezzati M(2005)Role of smoking in global and regional cancer epidemiology: current patterns and data needs Int J Cancer 116 963-971

[2] Henley SJ(2003)Estimates of global mortality attributable to smoking in 2000 Lancet 362 847-852

[3] Lopez AD(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[4] Thun MJ(2011)Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 395-409

[5] Ezzati M(2001)Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner Br J Cancer 84 25-32

[6] Lopez AD(2003)Lung cancer screening with CT: Mayo Clinic experience Radiology 226 756-761

[7] Jemal A(1995)Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Breast Cancer Res Treat 36 169-180

[8] Bray F(2012)Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed? Cancer Biol Ther 13 247-263

[9] Center MM(2012)Present status and problems on molecular targeted therapy of cancer Cancer Res Treat 44 1-10

[10] Ferlay J(2003)Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow J Clin Oncol 21 4428-4438

[1] Ezzati M(2005)Role of smoking in global and regional cancer epidemiology: current patterns and data needs Int J Cancer 116 963-971

[2] Henley SJ(2003)Estimates of global mortality attributable to smoking in 2000 Lancet 362 847-852

[3] Lopez AD(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[4] Thun MJ(2011)Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 395-409

[5] Ezzati M(2001)Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner Br J Cancer 84 25-32

[6] Lopez AD(2003)Lung cancer screening with CT: Mayo Clinic experience Radiology 226 756-761

[7] Jemal A(1995)Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Breast Cancer Res Treat 36 169-180

[8] Bray F(2012)Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed? Cancer Biol Ther 13 247-263

[9] Center MM(2012)Present status and problems on molecular targeted therapy of cancer Cancer Res Treat 44 1-10

[10] Ferlay J(2003)Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow J Clin Oncol 21 4428-4438